NCT00095524

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

A Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

Conditions

• Body Weight Change
• Schizophrenia
• Schizoaffective Disorder
• Psychotic Disorder

Interventions

Type	Name	Description
DRUG	Aripiprazole

Timeline

• Start date: 2004-03-01
• Primary completion: 2006-08-01
• Completion: 2006-08-01
• First posted: 2004-11-08
• Last updated: 2013-11-11

Locations

32 sites across 3 countries: United States, Brazil, United Kingdom